Peer Review History: Determining Maximum Recommended Starting Dose of Systemically Administered Biologics in First in Human Clinical Trials

Editor(s):

(1) Dr. Ashish Anand, GV Montgomery Veteran Affairs Medical Center, Jackson, MS, USA.

Reviewers:

(1) Mohamed Zahran, Alexandria University, Egypt.

(2) Bruna Pereira Nagamine, College New Sale of Imgrant, Brazil.

(3) Aman Shrivastava, Institute of Pharmaceutical Research, G.L.A University, India.

Additional Reviewers:

(1) Ali A. Al-Allaq, Helwan University, Egypt.

(2) Mohammad Daud Ali, Mohammed Al-Mana College for Medical Sciences, Saudi Arabia.

(3) Nabeel I. Allawi, Al-Amarah University College, Iraq.

(4) Rana Kadhim Mohammed, University of Baghdad, Iraq.

(5) Sepriadi, Universitas Negeri Padang, Indonesia.

(6) Tania Hunziker, Schwitzerland.

(7) Vijay Kumar Mishra, Public Health Foundation of India, India.

(8) Samuel Macedo Costa, University of Sao Paulo, Brazil.

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 8/10

Average Peer review marks at publication stage: 9.5/10

Peer Review History:


Stage 1 | Original Manuscript | File 1 | NA


Stage 2 | Peer review report_1 (Mohamed Zahran, Egypt) | File 1 | NA


Stage 2 | Peer review report_2 (Bruna Pereira Nagamine, Brazil) | File 1 | NA


Stage 2 | Peer review report_3 (Aman Shrivastava, India) | File 1 | NA


Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2


Stage 3 | Comment_Editor_1_v1 | File 1 | NA


Posted in Review History.